Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype

被引:113
作者
Atzei, A [1 ]
Gajewska, K [1 ]
Huggon, IC [1 ]
Allan, L [1 ]
Nicolaides, KH [1 ]
机构
[1] Kings Coll Hosp London, Sch Med, Harris Birthright Res Ctr Fetal Med, London SE5 9RS, England
关键词
cardiac defects; fetal echocardiography; nuchal translucency;
D O I
10.1002/uog.1936
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objective To define the prevalence of major cardiac defects according to nuchal translucency (NT) thickness at the 11 to 13 + 6-week scan in fetuses with normal karyotype. Methods Specialist fetal echocardiography was carried in 6921 fetuses with normal or presumed normal karyotype at a median gestation of 20 (range 12-35) weeks. The indications for fetal echocardiography were increased NT thickness (n = 3444), detailed second-trimester scan either for assessment of risk of chromosomal abnormalities (n = 2980) or previous or family history of fetal defects (n = 497). The cardiac defects were grouped into six functional categories: septal defect, left inflow obstruction, right inflow obstruction, left outflow obstruction, right outflow obstruction and other. Results Major cardiac defects were identified in 132 (19.1 per 1000) fetuses and the prevalence increased with fetal NT thickness from 4.9 per 1000 in those with NT below the median, to 8.7 for NT between the median and less than the 95(th) centile, 18.2 for NT between the 95(th) and 99(th) centiles, and exponentially thereafter to 35.2, 64.4 and 126.7 for respective NTs of 3.5-4.4 mm, 4.5-5.4 mm and >= 5.5 mm. There was no obvious difference in the distribution of NT in the different types of cardiac defects. Conclusions The prevalence of major cardiac defects increases exponentially with fetal NT thickness and in fetuses with NT of 3.5 mm or more it is higher than in pregnancies with a family history of cardiac defects. Copyright (c) 2005 ISUOG. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:154 / 157
页数:4
相关论文
共 9 条
[1]  
ALLAN LD, 1995, BRIT HEART J, V74, P103
[2]   Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study [J].
Hyett, J ;
Perdu, M ;
Sharland, G ;
Snijders, R ;
Nicolaides, KH .
BRITISH MEDICAL JOURNAL, 1999, 318 (7176) :81-85
[3]   Screening performance of first-trimester nuchal translucency for major cardiac defects: A meta-analysis [J].
Makrydimas, G ;
Sotiriadis, A ;
Ioannidis, JPA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (05) :1330-1335
[4]   Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses [J].
Michailidis, GD ;
Economides, DL .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 17 (02) :102-105
[5]   FETAL NUCHAL TRANSLUCENCY - ULTRASOUND SCREENING FOR CHROMOSOMAL DEFECTS IN 1ST TRIMESTER OF PREGNANCY [J].
NICOLAIDES, KH ;
AZAR, G ;
BYRNE, D ;
MANSUR, C ;
MARKS, K .
BRITISH MEDICAL JOURNAL, 1992, 304 (6831) :867-869
[6]   Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities [J].
Nicolaides, KH .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (01) :45-67
[7]  
*OFF NAT STAT, 2002, MORT STAT, P35
[8]   UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation [J].
Snijders, RJM ;
Noble, P ;
Sebire, N ;
Souka, A ;
Nicolaides, KH .
LANCET, 1998, 352 (9125) :343-346
[9]   Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester [J].
Souka, AP ;
Krampl, E ;
Bakalis, S ;
Heath, V ;
Nicolaides, KH .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (01) :9-17